Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices

American Journal of Infection Control

Volumn 24, Issue 1, 1996, Pages 24-31

  Garner, J S ^a   Hierholzer Jr , W J ^a   McCormick, R D ^a   Adams, A B ^a   Craven, D E ^a   Fleming, D W ^a   Forlenza, S W ^a   Gilchrist, M J ^a   Goldmann, D A ^a   Larson, E L ^a   Mayhall, C G ^a   Nichols, R L ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD ANALYSIS; BODY FLUID; CLEANING; DISEASE TRANSMISSION; FECES ANALYSIS; HAND WASHING; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; PATIENT CARE; PATIENT TRANSPORT; PRACTICE GUIDELINE; PROTECTIVE CLOTHING; REVIEW; SALIVA ANALYSIS; SPUTUM ANALYSIS; URINALYSIS; WOUND DRAINAGE;

EID: 13344294398     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(96)90050-4     Document Type: Review

References (106)

1. Garner JS. The CDC Hospital Infection Control Practices Advisory Committee. AM J INFECT CONTROL 1993;21:160-2.
2. National Communicable Disease Center. Isolation techniques for use in hospitals. Washington, DC: US Government Printing Office; 1970. PHS publication 2054.
3. Center for Disease Control. Isolation techniques for use in hospitals, 2nd ed. Washington, DC: US Government Printing Office; 1975. HHS publication (CDC) 80-8314.
4. Garner JS, Simmons BP. CDC guideline for isolation precautions in hospitals. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta; 1983. HHS Publ. No. (CDC) 83-8314; Infect Control 1983;4:245-325. AM J INFECT CONTROL 1984;12:103-63.
5. Garner JS, Simmons BP. CDC guideline for isolation precautions in hospitals. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta; 1983. HHS Publ. No. (CDC) 83-8314; Infect Control 1983;4:245-325. AM J INFECT CONTROL 1984;12:103-63.
6. Garner JS, Simmons BP. CDC guideline for isolation precautions in hospitals. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta; 1983. HHS Publ. No. (CDC) 83-8314; Infect Control 1983;4:245-325. AM J INFECT CONTROL 1984;12:103-63.
7. Lynch T. Communicable disease nursing. St. Louis: Mosby, 1949.
8. Gage ND, Landon JF, Sider MT. Communicable disease. Philadelphia: FA Davis, 1959.
9. Haley RW, Shachtman RH. The emergence of infection surveillance and control programs in U.S. hospitals: an assessment, 1976. Am J Epidemiol 1980;111:574-91.
10. Schaffner W. Infection control: old myths and new realities. Infect Control 1980;1:330-4.
11. Garner JS. Comments on CDC guideline for isolation precautions in hospitals, 1984. AM J INFECT CONTROL 1984;12:163-4.
12. Haley RW, Garner JS, Simmons BP. A new approach to the isolation of patients with infectious diseases: alternative systems. J Hosp Infect 1985;6:128-39.
13. Nauseef WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981;304:448-53.
14. Pizzo PA. The value of protective isolation in preventing nosocomial infections in high risk patients. Am J Med 1981;70:631-7.
15. Jacobson JT, Johnson DS, Ross CA, Conti MT, Evans RS, Burke JP. Adapting disease-specific isolation guidelines to a hospital information system. Infect Control 1986;7: 411-8.
16. Goldmann DA. The role of barrier precautions in infection control. J Hosp Infect 1991;18:515-23.
17. Goldmann DA, Platt R, Hopkins C. Control of hospital-acquired infections. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. Philadelphia: WB Saunders, 1992:378-90.
18. Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. MMWR 1988;37(3S): 1-16.
19. Centers for Disease Control. Risks associated with human parvovirus B19 infection. MMWR 1989;38:81-8,93-7.
20. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990;39(RR-17):1-29.
21. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital - Florida. MMWR 1990;39:718-22.
22. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991; 40:585-91.
23. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1993;42(RR-7):1-8.
24. Centers for Disease Control and Prevention, Draft guidelines for preventing the transmission of tuberculosis in health-care facilities, second edition. Federal Register 1993;58(195):52810-52850.
25. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1-132; Federal Register 1994;59(208):54242-54303.
26. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1-132; Federal Register 1994;59(208):54242-54303.
27. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34:681-6,691-5.
28. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR 1986;35:221-3.
29. Centers for Disease Control. Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR 1987;36:285-9.
30. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(2S):1S-18S.
31. Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;37:377-82,387-8.
32. Lynch P, Jackson MM, Cummings MJ, Stamm, WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107: 243-6.
33. Lynch P, Cummings MJ, Roberts PL, Herriott MJ, Yates B, Stamm WE. Implementing and evaluating a system of generic infection precautions: body substance isolation. AM J INFECT CONTROL 1990;18:1-12.
34. McPherson DC, Jackson MM, Rogers JC. Evaluating the cost of the body substance isolation system. J Healthcare Material Mgmt 1988;6:20-8.
35. Patterson JE, Vecchio J, Pantelick EL, Farrel P, Mazon D, Zervos MJ, Hierholzer WJ. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med 1991;91:479-83.
36. Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989;320:1714-21.
37. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Gold mann DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with gown and glove isolation precautions. N Engl J Med 1987;317:329-34.
38. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981;70:449-54.
39. Garner JS, Hierholzer WJ. Controversies in isolation policies and practices. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 2nd ed. Baltimore: Williams & Wilkins, 1993:70-81.
40. Garner JS, Hughes JM. Options for isolation precautions. Ann Intern Med 1987;107:248-50.
41. Weinstein RA, Kabins SA. Isolation practices in hospitals [Letter]. Ann Intern Med 1987;107:781-2.
42. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing. Ann Intern Med 1988;109:394-8.
43. Sussman GL, Tarlo S, Dolovich J. The spectrum of IgE-mediated response to latex. JAMA 1991;255:2844-7.
44. Bubak ME, Reed CE, Fransway AF, et al. Allergic reactions to latex among health-care workers. Mayo Clin Proc 1992;67:1075-9.
45. Albert RK, Condie F. Hand-washing patterns in medical intensive care units. N Engl J Med 1981;304:1465-6.
46. Preston GA, Larson EL, Stamm WE. The effect of private isolation rooms on patient care practices, colonization and infection in an intensive care unit. Am J Med 1981;70: 641-5.
47. Larson E, Leyden JJ, McGinley KJ, Grove GL, Talbot GH. Physiologic and microbiologic changes in skin related to frequent handwashing. Infect Control 1986;7:59-63.
48. Department of Labor. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; proposed rule and notice of hearings. Federal Register 1989;54(102):23042-23139.
49. Doebbeling BN, Wenzel RP. The direct costs of universal precautions in a teaching hospital. JAMA 1990;264: 2083-7.
50. Eickhoff TC. The cost of prevention. Infect Dis News 1991;4:6.
51. Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145-53.
52. Klein RS. Universal precautions for preventing occupational exposures to human immunodeficiency virus type 1. Am J Med 1991;90:141-53.
53. Wong ES, Stotka JL, Chinchilli VM, Williams DS, Stuart CG, Markowitz SM. Are universal precautions effective in reducing the number of occupational exposures among health care workers? JAMA 1991;265:1123-8.
54. Department of Labor. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. Federal Register 1991;56(235): 64175-64182.
55. American Hospital Association. OSHA's final bloodborne pathogens standard: a special briefing. Chicago; American Hospital Association, 1992. Item No. 155904.
56. Bruning LM. The bloodborne pathogens final rule. AORN J 1993;57:439-61.
57. Jackson MM, Lynch P. An attempt to make an issue less murky: a comparison of four systems for infection precautions. Infect Control Hosp Epidemiol 1991;12:448-50.
58. Pugliese G, Lynch P, Jackson MM. Universal precautions: policies, procedures, and resources. Chicago: American Hospital Association, 1991:7-87.
59. Birnbaum D, Schulzer M, Mathias RG, Kelly M, Chow AW. Adoption of guidelines for universal precautions and body substance isolation in Canadian acute-care hospitals. Infect Control Hosp Epidemiol 1990;11:465-72.
60. Lynch P, Cummings MJ, Stamm WE, Jackson MM. Handwashing versus gloving [Letter], Infect Control Hosp Epidemiol 1991;12:139.
61. Birnbaum D, Schulzer M, Mathias RG, Kelly M, Chow AW. Handwashing versus gloving [Letter]. Infect Control Hosp Epidemiol 1991;12:140.
62. Gurevich I. Body substance isolation [Letter]. Infect Control Hosp Epidemiol 1992;13:191.
63. Jackson MM, Lynch P. Body substance isolation [Letter]. Infect Control Hosp Epidemiol 1992;13:191-2.
64. Rudnick JR, Kroc K, Manangan L, Banerjee S, Pugliese G, Jarvis W. Are U.S. hospitals prepared to control nosocomial transmission of tuberculosis? [Abstract]. Annu Conf Epidemic Intelligence Srv 1993:60.
65. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press, 1992.
66. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1983. MMWR 1993;42:597-9.
67. Lowbury EJL, Lilly HA, Bull JP. Disinfection of hands: removal of transient organisms. Br Med J 1964;2: 230-3.
68. Sprunt K, Redmon W, Leidy G. Antibacterial effectiveness of routine handwashing. Pediatrics 1973;52:264-71.
69. Steere AC, Mallison GF. Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975;83:683-90.
70. Food and Drug Administration. The tentative final monograph for over-the-counter topical antimicrobial products. Federal Register 1978;43:1210-1249.
71. Garner JS, Favero MS. Guideline for handwashing and hospital environmental control. Atlanta: US Department of Health and Human Services, Public Health Service, CDC, 1985.
72. Larson E. APIC guideline for use of topical antimicrobial products. AM J INFECT CONTROL 1988;16:253-66.
73. Ehrenkranz NJ. Bland soap handwash or hand antisepsis? the pressing need for clarity. Infect Control Hosp Epidemiol 1992;13:299-301.
74. Larson E. Skin cleansing. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 2nd ed. Baltimore: Williams and Wilkins, 1993:450-9.
75. Larson EL, 1992, 1993, and 1994 Association for Professionals in Infection Control and Epidemiology Guidelines Committee. APIC guideline for handwashing and hand antisepsis in health care settings. AM J INFECT CONTROL 1995;23:251-69.
76. Paulssen J, Eidem T, Kristiansen R. Perforations in surgeons' gloves. J Hosp Infect 1988;11:82-5.
77. DeGroot-Kosolcharoen J, Jones JM. Permeability of latex and vinyl gloves to water and blood. AM J INFECT CONTROL 1989;17:196-201.
78. Kotilainen HR, Brinker JP, Avato JL, Gantz NM. Latex and vinyl examination gloves: quality control procedures and implications for health care workers. Arch Intern Med 1989;149:2749-53.
79. Olsen RJ, Lynch P, Coyle MB, Cummings MJ, Bokete T, Stamm WE. Examination gloves as barriers to hand contamination and clinical practice. JAMA 1993;270: 350-3.
80. Health Resources and Services Administration. Guidelines for construction and equipment of hospital and medical facilities. Rockville, Maryland: US Department of Health & Human Services, Public Health Service, 1984. PHS publication (HRSA) 84-14500.
81. American Institute of Architects (AIA), Committee on Architecture for Health. General hospital. In: Guidelines for construction and equipment of hospital and medical facilities. Washington, DC: The American Institute of Architects Press, 1993: chap 7.
82. American Society of Heating, Refrigerating, and Air Conditioning Engineers. Health facilities. In: 1991 Application Handbook. Atlanta: American Society of Heating, Refrigerating, and Air Conditioning Engineers, Inc., 1991: chap 7.
83. Jarvis WR, Bolyard EA, Bozzi CJ, et al. Respirators, recommendations, and regulations: the controversy surrounding protection of health care workers from tuberculosis. Ann Intern Med 1995;122:142-6.
84. Department of Health and Human Services and Department of Labor. Respiratory protective devices; final rules and notice. Federal Register 1995;60(110):30336-30402.
85. Rutula WA, Mayhall CG. The Society for Hospital Epidemiology of America Position paper: medical waste. Infect Control Hosp Epidemiol 1992;13:38-48.
86. Rhame FS. The inanimate environment. In: Bennett JV, Brachman PS, eds. Hospital infections. 3rd ed. Boston: Little, Brown and Co, 1992:299-333.
87. Rutula WA. Disinfection, sterilization, and waste disposal. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 2nd ed. Baltimore: Williams and Wilkins, 1993:460-95.
88. Maki DG, Alvarado C, Hassemer C. Double-bagging of items from isolation rooms is unnecessary as an infection control measure: a comparative study of surface contamination with single and double-bagging. Infect Control 1986;7:535-7.
89. American Society for Healthcare Central Services. Recommended practices for central service: sterilization. Chicago: American Hospital Association, 1988.
90. American Society for Healthcare Central Services. Recommended practices for central service: decontamination. Chicago: American Hospital Association, 1990.
91. Rutula WA. APIC guideline for selection and use of disinfectants. AM J INFECT CONTROL 1990;18:99-117.
92. Bond WW, Ott BJ, Franke KA, McCracken JE. Effective use of liquid chemical germicides on medical devices: instrument design problems. In: Block SS, ed. Disinfection, sterilization, and preservation. 4th ed. Philadelphia: Lea and Febiger, 1991:1097-106.
93. Favero MS, Bond WW. Sterilization, disinfection, and antisepsis. In: Ballows A, Hausler WJ, Herrmann KL, Isenberg HO, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington: American Society for Microbiology 1991:183-200.
94. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea and Febiger, 1991:617-41.
95. Pugliese G, Hunstiger CA. Central services, linens, and laundry. In: Bennett JV, Brachman PS, eds. Hospital infections. 3rd ed. Boston: Little, Brown and Co, 1992: 335-44.
96. Joint Committee on Healthcare Laundry Guidelines. Guidelines for healthcare linen service - 1994. Hallandale, Florida: Textile Rental Services Association of America, 1994.
97. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. AM J INFECT CONTROL 1995;23:87-94; Infect Control Hosp Epidemiol 1995;16:105-13; MMWR 1995; 44(No. RR-12):1-13.
98. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. AM J INFECT CONTROL 1995;23:87-94; Infect Control Hosp Epidemiol 1995;16:105-13; MMWR 1995; 44(No. RR-12):1-13.
99. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. AM J INFECT CONTROL 1995;23:87-94; Infect Control Hosp Epidemiol 1995;16:105-13; MMWR 1995; 44(No. RR-12):1-13.
100. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia: part I. Issues on prevention of nosocomial pneumonia - 1994. AM J INFECT CONTROL 1994;22: 247-66;
101. Infect Control Hosp Epidemiol 1994;15:587-604;
102. Respir Care 1994;12:1191-209.
103. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia: part II. Recommendations for prevention of nosocomial pneumonia. AM J INFECT CONTROL 1994;22:266-92; Infect Control Hosp Epidemiol 1994;15:604-27; Respir Care 1994;12:1209-36.
104. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia: part II. Recommendations for prevention of nosocomial pneumonia. AM J INFECT CONTROL 1994;22:266-92; Infect Control Hosp Epidemiol 1994;15:604-27; Respir Care 1994;12:1209-36.
105. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia: part II. Recommendations for prevention of nosocomial pneumonia. AM J INFECT CONTROL 1994;22:266-92; Infect Control Hosp Epidemiol 1994;15:604-27; Respir Care 1994;12:1209-36.
106. Centers for Disease Control and Prevention. Update: management of patients with suspected viral hemorrhagic fever - United States. MMWR 1995;44:475-9.